Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for G Medical Innovations Holdings's Pretax Margin % or its related term are showing as below:
GMVDF's Pretax Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.18 * Ranked among companies with meaningful Pretax Margin % only.
G Medical Innovations Holdings (OTCPK:GMVDF) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
G Medical Innovations Holdings Pretax Margin % Related Terms
G Medical Innovations Holdings Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
G Medical Innovations Holdings Pretax Margin % Chart
GMVDF vs WHSI, ISRG, BDX: Pretax Margin % Comparison
For the Medical Devices subindustry, G Medical Innovations Holdings's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
G Medical Innovations Holdings Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, G Medical Innovations Holdings's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where G Medical Innovations Holdings's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
G Medical Innovations Holdings (GMVDF) has a Pretax Margin % of -30.42% as of Dec. 2022. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on G Medical Innovations Holdings and its competitors.
Is G Medical Innovations Holdings' Pretax Margin % too high?
G Medical Innovations Holdings' current Pretax Margin % is -30.42%. Overall, G Medical Innovations Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does G Medical Innovations Holdings' Pretax Margin % compare to WHSI and ISRG?
G Medical Innovations Holdings' Pretax Margin % of -30.42% can be compared against companies in the Medical Devices & Instruments industry. The industry median Pretax Margin % is 2.18. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.18, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on G Medical Innovations Holdings and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. G Medical Innovations Holdings's current Pretax Margin % is -30.42%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is G Medical Innovations Holdings stock overvalued right now?
G Medical Innovations Holdings (GMVDF) has a current Pretax Margin % of -30.42%. The current Pretax Margin % is -30.42%. G Medical Innovations Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For G Medical Innovations Holdings (GMVDF), the current Pretax Margin % is -30.42% as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
G Medical Innovations Holdings Ltd is a mobile health (mHealth), telemedicine solutions, and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. The company offers a suite of both consumer and clinical grade products and platforms which are positioned to reduce inefficiencies in healthcare delivery, improve access, reduce costs, increase the quality of care, and make healthcare more personalized and precise. Its operating segment includes Products, Patient Services, and Covid-19 testing. The company generates maximum revenue from the Patient Services segment.
12GF Score
Get the complete analysis for GMVDF
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GMVDF has been successfully added to your 
